Clinical Trial Update: Pharmacokinetic Study to Compare the Blood Levels of Abatacept Manufactured at Lonza Biologics to the Blood Levels of Abatacept Manufactured at the Devens, Massachusetts (MA) Facility of Bristol-Myers Squibb [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study comparing abatacept produced at Lonza Biologics with abatacept produced at Bristol-Myers Squibb's Devens facility to evaluate bloo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ORENCIA (ABATACEPT)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED | Results posted: 2014-02-04